October 16, 2023 By Jim Hammerand Henry Schein discloses ‘cybersecurity incident’ under new SEC rules
October 6, 2023 By MDO Contributors Network Why linking clinical trials to real-world data is the critical next step for medical device development
October 5, 2023 By MDO Staff Nissha Medical Technologies wins FDA approval of its HeartSync defibrillation electrodes
October 2, 2023 By Jim Hammerand Resonetics closes $900M nitinol deal and rebrands Memry and Smart Materials
September 22, 2023 By Jim Hammerand Synchron’s plan to beat Neuralink in the neuroprosthetic BCI race
September 19, 2023 By MDO Staff S3 Connected Health joins DiMe’s International Regulatory Pathways project
September 15, 2023 By Jim Hammerand These devices are the top targets of lawsuit-related advertisements
September 13, 2023 By Jim Hammerand FTC concludes antitrust investigation of $900M SAES-Resonetics nitinol deal
September 7, 2023 By MDO Contributors Network Three steps for traceability in medical device software development quality and compliance
August 24, 2023 By Jim Hammerand After Medtronic’s latest setback, what’s next for Symplicity Spyral RDN?
August 23, 2023 By Jim Hammerand Risks of Medtronic Symplicity Spyral renal denervation (RDN) outweigh benefits: FDA review panel
August 14, 2023 By Jim Hammerand Medtronic moves its 2023 annual meeting up for first time since HQ move